{"id":"https://openalex.org/W2181719829","doi":null,"title":"A RETROSPECTIVE STUDY ON THE POTENTIAL DRUG INTERACTION BETWEEN ANGIOTE NSIN CONVERTING ENZYME INHIBITOR OR ANGIOTENSIN RECEPTOR ANTAGONIST AND OTHER DRUGS IN END - STAGE CHRONIC RENAL FAILURE PATIENTS","display_name":"A RETROSPECTIVE STUDY ON THE POTENTIAL DRUG INTERACTION BETWEEN ANGIOTE NSIN CONVERTING ENZYME INHIBITOR OR ANGIOTENSIN RECEPTOR ANTAGONIST AND OTHER DRUGS IN END - STAGE CHRONIC RENAL FAILURE PATIENTS","publication_year":2012,"publication_date":"2012-10-01","ids":{"openalex":"https://openalex.org/W2181719829","mag":"2181719829"},"language":"en","primary_location":{"id":"pmh:oai:ojs2.irjponline.org:article/2968","doi":null,"is_oa":true,"landing_page_url":"http://irjponline.org/index.php/irjp/article/view/2968","pdf_url":null,"source":{"id":"https://openalex.org/S4210205243","display_name":"International Research Journal of Pharmacy","issn_l":"2230-8407","issn":["2230-8407"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20"],"host_organization":"https://openalex.org/P4360969348","host_organization_name":"Moksha Publishing House","host_organization_lineage":["https://openalex.org/P4360969348"],"host_organization_lineage_names":["Moksha Publishing House"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2230-8407","raw_type":"info:eu-repo/semantics/article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://irjponline.org/index.php/irjp/article/view/2968","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028662270","display_name":"Honey Iskandar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Honey Iskandar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048288109","display_name":"Wahyudi Uun Hidayat","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wahyudi Uun Hidayat","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034499961","display_name":"Yetti Hersunaryati","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yetti Hersunaryati","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5027277592","display_name":"Syamsudin Syamsudin","orcid":"https://orcid.org/0000-0003-3053-8648","observed_orcids":["https://orcid.org/0000-0003-3053-8648"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Syamsudin Syamsudin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.28144635,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"3","issue":"10","first_page":"86","last_page":"89"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.9193999767303467,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.9193999767303467,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10291","display_name":"Dialysis and Renal Disease Management","score":0.028599999845027924,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12876","display_name":"Potassium and Related Disorders","score":0.007899999618530273,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.8840000033378601},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.8830000162124634},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9729999899864197},{"id":"https://openalex.org/keywords/hemodialysis","display_name":"hemodialysis","score":0.8220000267028809},{"id":"https://openalex.org/keywords/polypharmacy","display_name":"polypharmacy","score":0.9369999766349792},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9829999804496765},{"id":"https://openalex.org/keywords/hyperkalemia","display_name":"hyperkalemia","score":0.9470000267028809},{"id":"https://openalex.org/keywords/hypotension","display_name":"hypotension","score":0.8389999866485596},{"id":"https://openalex.org/keywords/renal-function-decline","display_name":"renal function decline","score":0.7519999742507935},{"id":"https://openalex.org/keywords/captopril","display_name":"captopril","score":0.8399999737739563},{"id":"https://openalex.org/keywords/valsartan","display_name":"valsartan","score":0.8029999732971191},{"id":"https://openalex.org/keywords/lisinopril","display_name":"lisinopril","score":0.7630000114440918},{"id":"https://openalex.org/keywords/furosemide","display_name":"furosemide","score":0.7039999961853027}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8768682479858398},{"id":"https://openalex.org/C2779479957","wikidata":"https://www.wikidata.org/wiki/Q421119","display_name":"Captopril","level":3,"score":0.8068011999130249},{"id":"https://openalex.org/C2777880890","wikidata":"https://www.wikidata.org/wiki/Q412208","display_name":"Lisinopril","level":4,"score":0.7040414810180664},{"id":"https://openalex.org/C2777955127","wikidata":"https://www.wikidata.org/wiki/Q388801","display_name":"Furosemide","level":2,"score":0.6194472312927246},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.5553452968597412},{"id":"https://openalex.org/C2779611605","wikidata":"https://www.wikidata.org/wiki/Q288280","display_name":"ACE inhibitor","level":4,"score":0.5298224091529846},{"id":"https://openalex.org/C2778063415","wikidata":"https://www.wikidata.org/wiki/Q391744","display_name":"Hemodialysis","level":2,"score":0.4863782227039337},{"id":"https://openalex.org/C3019040382","wikidata":"https://www.wikidata.org/wiki/Q476921","display_name":"End stage renal disease","level":3,"score":0.4837467670440674},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.48136264085769653},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.43975016474723816},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4204736351966858},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3876366913318634},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.25003570318222046},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:ojs2.irjponline.org:article/2968","doi":null,"is_oa":true,"landing_page_url":"http://irjponline.org/index.php/irjp/article/view/2968","pdf_url":null,"source":{"id":"https://openalex.org/S4210205243","display_name":"International Research Journal of Pharmacy","issn_l":"2230-8407","issn":["2230-8407"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20"],"host_organization":"https://openalex.org/P4360969348","host_organization_name":"Moksha Publishing House","host_organization_lineage":["https://openalex.org/P4360969348"],"host_organization_lineage_names":["Moksha Publishing House"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2230-8407","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:2181719829","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/dd658af3557d4ef88462c742709c3ad5","pdf_url":null,"source":{"id":"https://openalex.org/S2765004438","display_name":"Asian Journal of Research in Chemistry","issn_l":"0974-4150","issn":["0974-4150","0974-4169"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4323253580","host_organization_name":"PANhealth Care Research Society","host_organization_lineage":["https://openalex.org/P4323253580"],"host_organization_lineage_names":["PANhealth Care Research Society"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Asian Journal of Research in Chemistry","raw_type":null}],"best_oa_location":{"id":"pmh:oai:ojs2.irjponline.org:article/2968","doi":null,"is_oa":true,"landing_page_url":"http://irjponline.org/index.php/irjp/article/view/2968","pdf_url":null,"source":{"id":"https://openalex.org/S4210205243","display_name":"International Research Journal of Pharmacy","issn_l":"2230-8407","issn":["2230-8407"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20"],"host_organization":"https://openalex.org/P4360969348","host_organization_name":"Moksha Publishing House","host_organization_lineage":["https://openalex.org/P4360969348"],"host_organization_lineage_names":["Moksha Publishing House"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2230-8407","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1964878544","https://openalex.org/W1984775628","https://openalex.org/W2016341825","https://openalex.org/W2023943834","https://openalex.org/W2123196786","https://openalex.org/W2194829709","https://openalex.org/W2487377689"],"related_works":["https://openalex.org/W2051816952","https://openalex.org/W7215887639","https://openalex.org/W4206090904","https://openalex.org/W3113165706","https://openalex.org/W2942435340","https://openalex.org/W4388238389","https://openalex.org/W2889693808","https://openalex.org/W7064313688","https://openalex.org/W2767196709","https://openalex.org/W3179681544"],"abstract_inverted_index":{"Increasing":[0],"number":[1,14],"of":[2,15,29,36,45,65,71,118,187,244,300,306,319],"chronic":[3,37,46],"renal":[4,38,47,274],"failure":[5,48],"(CRF)":[6],"patients":[7,16,35,55,82,152,193,210,285,307],"had":[8,67],"reflected":[9],"an":[10],"increase":[11,240],"in":[12,61,139,241,264,282,315],"the":[13,34,54,69,109,173,185,200,245,251,295],"with":[17,27,86,97,196,214,223],"diabetes":[18],"and":[19,158,169,204,208,217,226,236,254,272,303,317],"hypertension.":[20],"Therefore,":[21],"health":[22],"practitioners":[23],"would":[24,49],"be":[25],"faced":[26],"management":[28],"complicated":[30],"medical":[31],"problems":[32],"for":[33,143,297,301],"disease.":[39],"In":[40],"this":[41,313],"way,":[42],"various":[43],"complications":[44],"lead":[50],"to":[51,58,78,84,93],"polypharmacy,":[52],"where":[53],"receive":[56],"three":[57],"five":[59],"drugs":[60,162,220,246],"a":[62,140,144],"dose.":[63],"Development":[64],"polypharmacy":[66],"made":[68],"potential":[70],"drug":[72,89,280,322],"interaction":[73,281],"greater.":[74],"The":[75,104,125,135,257,277],"objective":[76],"was":[77,102,106,127,247],"determine":[79],"whether":[80],"CRF":[81,151,198,284],"admitted":[83],"hospital":[85],"specific":[87],"adverse":[88,242,258,321],"reactions":[90],"were":[91,137,154,194,211,228],"likely":[92],"have":[94,309],"been":[95],"prescribed":[96],"interacting":[98],"drugs.":[99],"Retrospective":[100],"study":[101,105,126,278,293],"designed.":[103],"conducted":[107,128],"at":[108,172,177,199],"General":[110,174],"Practice":[111,175],"Rooms":[112,176],"Floor":[113,116],"1":[114],"\u2013":[115,132,147,189],"VI":[117],"Central":[119,178,201],"Army":[120,179,202],"Hospital":[121,180,203],"Gatot":[122,181],"Soebroto":[123,182],"Jakarta.":[124,183],"from":[129],"December":[130,148,190],"2011":[131],"February":[133],"2012.":[134],"data":[136],"collected":[138],"retrospective":[141],"way":[142],"year":[145],"(January":[146],"2011).":[149],"End-stage":[150],"who":[153,286,308],"having":[155,205],"hemodialysis":[156,207],"therapy":[157,213],"receiving":[159,170,212],"ACE":[160,215,224,288],"Inhibitor":[161,216,225,289],"or":[163,290],"Angiotensin":[164],"II":[165],"Receptor":[166],"Antagonist":[167],"(AIIRA)":[168],"treatment":[171],"During":[184],"period":[186],"January":[188],"2011,":[191],"84":[192],"treated":[195],"end-stage":[197,283],"routine":[206],"44":[209],"AIIRA.":[218,291],"Other":[219],"simultaneously":[221],"given":[222],"AIIRA":[227],"captopril-spironolactone,":[229],"captopril-":[230],"aspirin,":[231],"captopril-allopurinol,":[232],"captopril-KSR,":[233],"captopril-furosemide,":[234],"lisinopril-furosemide":[235],"valsartan-mefenemic":[237],"acid.":[238],"An":[239],"effects":[243,259],"found":[248],"based":[249],"on":[250],"clinical":[252],"evaluation":[253],"laboratory":[255],"examination.":[256],"included":[260],"hyperkalemia":[261],"(9,09%),":[262],"decrease":[263],"anti-":[265],"hypertension":[266],"effect":[267],"(6,8%),":[268],"acute":[269],"hypotension":[270],"(40%),":[271],"declining":[273],"function":[275],"(11,36%).":[276],"identifies":[279],"received":[287],"This":[292],"highlights":[294],"need":[296],"screening":[298],"prescriptions":[299],"pDDIs":[302],"proactive":[304],"monitoring":[305],"identified":[310],"risk":[311],"factors;":[312],"helps":[314],"detection":[316],"prevention":[318],"possible":[320],"interactions.":[323]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-10T09:11:00.788812","created_date":"2016-06-24T00:00:00"}